$102.08
-$1.52
(-1.47%)
Quote as of 4:00 PM EST on 02/10/12
Regeneron Pharmaceuticals, Inc...
NASDAQ:REGN
|
$102.08
-$1.52
(-1.47%)
|
|
| Today's Open | $103.00 |
|---|---|
| Previous Close | $103.60 |
| Daily Range | $101.29 - $103.84 |
| 52-Week Range | $34.05 - $105.42 |
| Market Cap | $9.45B |
| P/E Ratio | -51.03 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 809,290 |
| Average Daily Volume | 1,408,820 |
| Current FY EPS | -$2.50 |
REGN Information
| Description |
|---|
| The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
EUROPEAN MIDDAY BRIEFING FROM DOW JONES NEWSWIRES
EUROPEAN MIDDAY BRIEFING FROM DOW JONES NEWSWIRES
EUROPEAN MIDDAY BRIEFING FROM DOW JONES NEWSWIRES
3 Lessons From the J.P. Morgan Health-Care Confab
REGN Projects Strong Q4 Eylea Sales - Analyst Blog
The Sector That's Delivering 2012's Biggest Winners
A Year's Worth of Sales in 1 Month
Regeneron Blows Away Sales Forecast for New Eye Drug
Regeneron Pharmaceuticals Shares Jumped: What You Need to Know
